Thermo Fisher Scientific: Q3 Earnings Insights

Shares of Thermo Fisher Scientific TMO rose 2% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 91.50% over the past year to $5.63, which beat the estimate of $4.31.

Revenue of $8,521,000,000 up by 35.86% from the same period last year, which beat the estimate of $7,650,000,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Oct 21, 2020

Time: 08:30 AM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.thermofisher.com%2Finvestors%2Fnews-and-events%2Fwebcasts-and-presentations%2Fevent-details%2F2020%2FQ3-2020-Thermo-Fisher-Scientific-Earnings-Conference-Call%2Fdefault.aspx&eventid=2395276&sessionid=1&key=E3F3C722007225D205F5D122BE8B15DB&regTag=&sourcepage=register

Technicals

Company's 52-week high was at $473.84

52-week low: $250.21

Price action over last quarter: Up 14.01%

Company Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (22% of sales); specialty diagnostic products (15%); life science solutions (27%); and lab products and services (42%).